Compounds > ampicillin
Page last updated: 2024-08-17

ampicillin and gentamicin c1

ampicillin has been researched along with gentamicin c1 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Abbas, SY; Ammar, YA; El Shehry, MF; Fayed, EA; Ghorab, MM; Shedid, SA1
Badavath, VN; Gangireddy, MR; Gundla, R; Maddipati, VC; Mandha, SR; Mantipally, M1
AbdelAziz, NA; Bondock, S; Fayad, W; Ibrahim, AB; Ibrahim, TM; Nasr, T; Sakr, TM1
Koksch, B; Mikolajczak, DJ; Roth, C; Thota, CK1
Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M1
Cho, E; Jang, S; Jeon, HI; Jeong, YJ; Kim, HK; Kim, K; Lee, D; Lee, E; Lee, Y; Min, SJ; Mun, SJ; Oh, JE; Son, W; Yang, CS; Yoo, HH1

Other Studies

6 other study(ies) available for ampicillin and gentamicin c1

ArticleYear
Quinoline derivatives bearing pyrazole moiety: Synthesis and biological evaluation as possible antibacterial and antifungal agents.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Chemistry Techniques, Synthetic; Drug Synergism; Fungi; Microbial Sensitivity Tests; Pyrazoles; Quinolines; Structure-Activity Relationship

2018
Rational design, molecular docking and synthesis of novel homopiperazine linked imidazo[1,2-a]pyrimidine derivatives as potent cytotoxic and antimicrobial agents.
    Bioorganic & medicinal chemistry letters, 2019, 08-15, Volume: 29, Issue:16

    Topics: A549 Cells; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Piperazine; Pyrimidines; Structure-Activity Relationship

2019
New acrylamide-sulfisoxazole conjugates as dihydropteroate synthase inhibitors.
    Bioorganic & medicinal chemistry, 2020, 05-01, Volume: 28, Issue:9

    Topics: Acrylamide; Anti-Bacterial Agents; Cells, Cultured; Dihydropteroate Synthase; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship; Sulfisoxazole

2020
Enhancing Antimicrobial Peptide Potency through Multivalent Presentation on Coiled-Coil Nanofibrils.
    ACS medicinal chemistry letters, 2021, Jan-14, Volume: 12, Issue:1

    Topics:

2021
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
    Bioorganic & medicinal chemistry, 2022, 01-15, Volume: 54

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells

2022
Discovery of
    Journal of medicinal chemistry, 2022, 01-13, Volume: 65, Issue:1

    Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Cytokines; Endosomes; High-Throughput Screening Assays; Mice; Mice, Knockout; Mycobacterium tuberculosis; Peptide Fragments; Reactive Oxygen Species; Sepsis; Serine Proteinase Inhibitors; Signal Transduction; Small Molecule Libraries; Sorting Nexins

2022